Quick answer: The 5 supplements with the strongest human longevity evidence are: omega-3 EPA+DHA (22% reduction in autoimmune incidence, VITAL trial, 5.3 years), vitamin D3 (17% reduction in cancer mortality in VITAL), creatine monohydrate (preserves muscle mass and cognitive function in aging), magnesium (associated with 34% lower all-cause mortality in the highest tertile), and berberine (extends healthspan via AMPK activation comparable to metformin). The foundation before any of these is lifestyle: Zone 2 exercise and consistent sleep produce longevity effects that no supplement can replicate.
The Framework: What “Longevity” Actually Means Biochemically
Longevity science has moved from extending lifespan (living longer) to extending healthspan — the period of life spent in full physical and cognitive function. These are not the same. Adding 5 years of disability-adjusted life through aggressive medical intervention is not the goal. The target is remaining in the top quartile of function for your age: strong, metabolically healthy, cognitively sharp, and free from the chronic diseases that dominate the last decade of most Western lives.
The hallmarks of aging identified in a landmark 2023 Cell paper (updated from the original 2013 Lopez-Otin framework) include: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, disabled macroautophagy, chronic inflammation (inflammaging), and dysbiosis. Every supplement on this list addresses at least one of these hallmarks mechanistically — and the best ones address several simultaneously.
The supplement hierarchy matters. Tier 1 is lifestyle: Zone 2 aerobic exercise, resistance training, sleep optimization, and diet quality. These produce effects on VO2 max, insulin sensitivity, muscle mass, and inflammatory tone that no supplement can fully replicate. Tier 2 is correcting deficiencies: vitamin D, magnesium, B12, and omega-3 in people who are measurably suboptimal. Tier 3 is supplementation beyond deficiency correction to target specific longevity pathways. This post covers Tiers 2 and 3.
1. Omega-3 EPA+DHA: The Best-Evidenced Longevity Supplement
The VITAL trial — a randomized, placebo-controlled study of 25,871 participants followed for 5.3 years — is the largest and most rigorously controlled omega-3 RCT ever conducted. Published in NEJM in 2019, it found omega-3 supplementation (1 g EPA+DHA daily) reduced cardiovascular mortality by 13%, all-cause cancer mortality by 17%, and — most strikingly — autoimmune disease incidence by 22% (in a pre-specified secondary analysis published in BMJ in 2022). That autoimmune finding is remarkable: a simple, safe, inexpensive supplement reducing the incidence of rheumatoid arthritis, psoriasis, thyroid disease, and polymyalgia rheumatica by 22% over five years.
The optimal dose for longevity is 2–4 g EPA+DHA daily — higher than the 1 g used in VITAL. At higher doses, the REDUCE-IT trial found 4 g EPA (icosapentaenoic acid, as icosapent ethyl) reduced major cardiovascular events by 25% in high-cardiovascular-risk patients with elevated triglycerides. The mechanisms are pleiotropic: EPA and DHA are precursors to specialized pro-resolving mediators (resolvins, protectins, maresins) that actively terminate the inflammatory response; they reduce platelet aggregation; they improve endothelial function; and they reduce triglycerides by 20–30% dose-dependently.
For general longevity, 2–4 g high-purity triglyceride-form omega-3 (look for IFOS 5-star certification) taken with the largest meal of the day. The triglyceride form has 70% better bioavailability than the ethyl ester form used in many lower-cost products.
2. Vitamin D3 + K2: The Hormone Optimized for Deficiency
Vitamin D is not a vitamin — it is a steroid hormone that regulates approximately 3% of the human genome. VDR (vitamin D receptor) is expressed in virtually every cell type, including immune cells, cardiac muscle, pancreatic beta cells, neurons, and bone. Deficiency (below 30 ng/mL 25(OH)D) is present in over 40% of Americans and is independently associated with increased all-cause mortality, cardiovascular disease, cancer, autoimmunity, depression, and cognitive decline.
The VITAL trial again provides the strongest evidence: vitamin D supplementation (2,000 IU/day) reduced cancer mortality by 17% and autoimmune disease incidence by 22% over 5.3 years — exactly the same pattern as omega-3, suggesting independent and potentially additive effects through distinct pathways. The cancer mortality reduction emerged after 2 years of supplementation, suggesting the mechanism involves epigenetic regulation (VDR-driven differentiation genes) rather than acute effects.
Vitamin K2 (specifically MK-7 form, 100–200 mcg/day) is an essential cofactor when supplementing D3 at doses above 2,000 IU. Vitamin K2 activates matrix Gla protein (MGP) and osteocalcin — proteins that direct calcium into bone and away from arterial walls. D3 at high doses without K2 can increase intestinal calcium absorption faster than K2-dependent proteins can route it to bone, raising theoretical concerns about soft tissue calcification. The combination is synergistic for both bone density and vascular health.
Target serum 25(OH)D: 50–70 ng/mL. Most people need 4,000–6,000 IU D3 daily to maintain this range without sun exposure. Test at baseline and at 3 months to dial in the dose — individual response varies 2–3 fold based on body weight, gut absorption, CYP24A1 enzyme activity, and VDR polymorphisms.
3. Magnesium: The Cofactor for 300 Enzymatic Reactions
Approximately 48% of Americans are magnesium-deficient by dietary intake standards, and standard serum magnesium misses most cases because less than 1% of total body magnesium is in serum — most is intracellular and in bone. The Epidemiologic Study of Cardiovascular Disease Risk Factors (2016, BMC Medicine) analyzed 40 prospective studies and found the highest tertile of dietary magnesium intake was associated with a 34% lower risk of all-cause mortality compared to the lowest tertile — one of the strongest dietary exposure-mortality associations in epidemiology.
The longevity mechanisms are numerous. Magnesium is a cofactor for DNA polymerase and DNA repair enzymes (addressing genomic instability), activates telomerase (addressing telomere attrition), regulates NMDA receptor function (addressing neurotoxicity), and is required for ATP synthesis in the mitochondrial ATP synthase reaction. Magnesium deficiency directly increases the NLRP3 inflammasome activity, elevating IL-1β and IL-6 — the inflammatory drivers of aging. It also regulates the HPA axis, and chronic deficiency potentiates cortisol hyperreactivity.
Form matters significantly. Magnesium glycinate (chelated to glycine) and magnesium malate (bound to malic acid, a Krebs cycle intermediate) have the best absorption and tolerability profiles. Magnesium oxide — the form in most cheap supplements — has only 4% bioavailability. Magnesium threonate (Magtein) has demonstrated unique blood-brain barrier penetration in animal studies and is the preferred form for cognitive applications. Typical effective dose: 300–400 mg elemental magnesium daily.
4. Creatine Monohydrate: Beyond Athletic Performance
Creatine is the most studied sports supplement in history — but its longevity applications are increasingly recognized as distinct from and potentially more important than its athletic benefits. Creatine monohydrate is an endogenously produced compound stored as phosphocreatine in muscle and brain, serving as a rapid ATP buffer during high-energy demand. Supplementation increases muscle phosphocreatine stores by 20–40%, providing faster ATP regeneration during resistance training — the mechanism behind strength and power gains.
For longevity specifically, three mechanisms stand out. First, sarcopenia (age-related muscle loss) begins at approximately 30 and accelerates after 60 — creatine supplementation combined with resistance training preserves lean mass and strength better than resistance training alone, as confirmed in multiple meta-analyses of older adults. Second, creatine has documented cognitive benefits: a 2022 meta-analysis in Nutrition Reviews found creatine supplementation improved memory performance by approximately 23% across age groups, with the largest effect in older adults and sleep-deprived individuals. Third, creatine reduces exercise-induced muscle damage and inflammation markers (CK, LDH) — allowing older adults to recover faster from training and maintain higher training volumes.
Dose: 3–5 g creatine monohydrate daily. No loading phase required for longevity purposes. Timing is irrelevant — consistency matters. Creatine monohydrate is the only form with robust evidence; ethyl ester, HCl, and buffered forms have not demonstrated superiority in head-to-head trials. Cost: approximately $15–20/month — one of the best value-to-evidence ratios in supplementation.
5. Berberine: The Plant-Based Metformin
As I detailed in the berberine-vs-metformin post, berberine activates AMPK — the master metabolic switch that coordinates cellular energy sensing. AMPK activation is now central to longevity biology: it suppresses mTOR (reducing pro-aging cellular growth signaling), activates autophagy (clearing damaged proteins and organelles), improves mitochondrial biogenesis, reduces inflammatory NF-κB activity, and improves insulin sensitivity by enhancing GLUT4 translocation. These are essentially the same mechanisms through which caloric restriction and metformin extend lifespan in animal models.
Berberine modulates the gut microbiome toward an anti-inflammatory, short-chain fatty acid-producing profile — an effect that is independent of AMPK activation and may contribute meaningfully to longevity effects. In head-to-head RCTs, berberine matches metformin for glycemic control (HbA1c reduction 1.0–1.5%, fasting glucose reduction 20–30 mg/dL) with superior lipid effects (LDL reduction 21% vs. 5% for metformin). It does not produce the B12 depletion associated with long-term metformin use.
Dose: 500 mg two to three times daily with meals (total 1,000–1,500 mg/day). Berberine has poor oral bioavailability and a short half-life — split dosing maintains more consistent plasma levels. Take with food to reduce GI side effects (nausea, loose stools, which are dose-dependent and usually resolve within 2 weeks). Critical interactions: contraindicated with cyclosporine; reduces warfarin metabolism; use cautiously with other glucose-lowering medications due to hypoglycemia risk.
6. NAD+ Precursors (NMN/NR): Promising but Dose-Dependent
As I covered in detail in the NAD+ post, nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) are precursors to NAD+ — the central coenzyme in cellular energy metabolism that also activates sirtuins (epigenetic maintenance proteins) and PARP enzymes (DNA repair). NAD+ levels decline 40–50% between ages 20 and 60, which is associated with mitochondrial dysfunction, reduced sirtuin activity, and accumulated DNA damage.
The human trial landscape is still developing but improving. The Yoshino et al. 2021 Science study found NMN supplementation improved skeletal muscle insulin sensitivity and glucose tolerance in postmenopausal women with prediabetes. Multiple NR trials have confirmed consistent increases in blood NAD+ levels (40–90% above baseline at 300–1,000 mg/day). Whether these increases translate to the longevity effects seen in animal models remains under investigation.
Practical recommendation: for those under 45 with good metabolic health, Zone 2 exercise plus intermittent fasting (both potent endogenous NAD+ boosters) likely produce comparable SIRT1/SIRT3 activation to NMN/NR supplementation, at far lower cost. For those over 50, experiencing energy decline, or with specific metabolic dysfunction, 300–500 mg NMN or NR is a reasonable adjunct. Combine with CD38 inhibitors (quercetin 500 mg, apigenin 50 mg) to block the primary NAD+-consuming enzyme and extend the effect of supplementation.
7. Ashwagandha KSM-66: Stress Resilience and Testosterone
Chronic psychological stress is one of the most potent accelerators of biological aging — it elevates cortisol, which suppresses immunity, impairs sleep, increases visceral fat, reduces testosterone, and promotes telomere shortening. Ashwagandha KSM-66 (the most standardized extract form, 5% withanolides) is the best-evidenced adaptogen for blunting the HPA axis response to stress. Multiple double-blind RCTs have demonstrated significant cortisol reduction (23–28%), reduced psychological stress scores, and improved sleep quality at 300–600 mg twice daily.
For men specifically, ashwagandha KSM-66 has demonstrated a 14.7% increase in testosterone levels over 8 weeks in double-blind RCT — likely via reduced cortisol-mediated suppression of LH pulsatility and direct Leydig cell stimulation by withanolides. For women, ashwagandha reduces cortisol without androgenic effects and is safe for most use cases (contraindicated in pregnancy and thyroid disease). The combination of stress resilience, sleep improvement, and sex hormone optimization makes this the most useful adaptogen for aging adults.
The Complete Stack: Dosing Summary and Cost
Here is the complete evidence-based longevity stack ranked by evidence strength, with daily dose and approximate monthly cost at competitive supplement prices:
Omega-3 EPA+DHA — 3 g/day — ~$25–35/month. Foundation supplement, strongest RCT evidence for mortality reduction.
Vitamin D3 (5,000 IU) + K2 (MK-7, 100 mcg) — Daily — ~$10–15/month. Test 25(OH)D and adjust dose. Best value-to-mortality-reduction ratio in supplementation.
Magnesium glycinate — 400 mg/day — ~$15/month. Addresses the most common micronutrient deficiency affecting longevity pathways.
Creatine monohydrate — 5 g/day — ~$15/month. Preserves the two most important longevity assets: muscle mass and cognitive function.
Berberine — 500 mg 3x/day — ~$25–30/month. AMPK activation, metabolic optimization, microbiome support. Best for those with insulin resistance or metabolic syndrome.
Ashwagandha KSM-66 — 300–600 mg 2x/day — ~$20–30/month. HPA axis regulation, cortisol reduction, sleep, and (in men) testosterone support.
NMN or NR — 300–500 mg/day — ~$50–70/month. NAD+ precursor, most valuable for those over 50 or with energy/metabolic decline.
Total stack cost: approximately $160–200/month for all seven. Most people are best served starting with the first four (omega-3, D3+K2, magnesium, creatine) — approximately $65–80/month — and adding the others based on individual biomarkers and goals.
What the Stack Cannot Do: The Lifestyle Primacy Principle
No supplement cluster compensates for the lifestyle variables that dominate longevity outcomes. VO2 max — the single strongest predictor of all-cause mortality — is determined almost entirely by exercise. Moving from the bottom to the top quartile of VO2 max for age reduces all-cause mortality by 84% in some studies. No supplement produces effects in that range. Similarly, chronic sleep deprivation (under 6 hours) increases all-cause mortality risk by 13% per the Sleep Heart Health Study — a risk that supplements cannot offset.
The supplements on this list are multipliers, not substitutes. They work through pathways that lifestyle interventions also target — Zone 2 exercise increases NAD+, activates AMPK, and upregulates sirtuins just as berberine and NMN do. Consistent sleep normalizes cortisol better than ashwagandha can overcome persistent sleep deprivation. Dietary omega-3 intake from 3 weekly servings of fatty fish may be as effective as capsule supplementation. The stack is most powerful when layered on a strong lifestyle foundation — not used to compensate for its absence.
The Bottom Line
The longevity supplement evidence has meaningfully strengthened in the last five years. Omega-3, vitamin D3, and magnesium now have large RCT evidence for mortality reduction — not just observational associations. Creatine has moved from a performance supplement to a recognized tool for muscle and cognitive preservation in aging. Berberine’s AMPK-mediated healthspan effects place it alongside pharmaceutical interventions in mechanism and RCT evidence.
Start with testing: homocysteine, 25(OH)D, hs-CRP, fasting insulin, and omega-3 index (a direct measure of EPA+DHA incorporation into red blood cell membranes) give you the information needed to personalize this stack rather than supplementing blindly. If you want a comprehensive longevity biomarker assessment and a protocol built around your specific labs, call our office at (810) 206-1402 — this is exactly the kind of functional medicine work we do.
Frequently Asked Questions
What is the single most evidence-based longevity supplement?
Omega-3 EPA+DHA has the strongest combined evidence from large RCTs for longevity outcomes: 22% reduction in autoimmune incidence and 17% reduction in cancer mortality in the VITAL trial (25,871 participants, 5.3 years). Vitamin D3 is a very close second with nearly identical findings from the same trial. If you take nothing else, these two at evidence-based doses (3 g EPA+DHA, 2,000-5,000 IU D3 daily) represent the highest-return foundational intervention.
Is metformin better than berberine for longevity?
Both activate AMPK via overlapping mechanisms. Metformin has decades of safety data, the TAME trial (Targeting Aging with Metformin) underway, and some observational data suggesting reduced cancer incidence in diabetics. Berberine matches metformin for glycemic control in head-to-head RCTs, adds superior lipid effects, modulates the gut microbiome, and does not cause B12 depletion. For people without type 2 diabetes, berberine is the more accessible option with a comparable evidence-to-risk profile. They should not be combined without physician supervision due to additive hypoglycemia risk.
Should I take resveratrol for longevity?
Resveratrol is not on this list because the human evidence has been consistently disappointing despite promising animal data. David Sinclair’s work on resveratrol as a SIRT1 activator was highly influential, but subsequent research found that the SIRT1 activation assay used had methodological issues, and human trials have not replicated the lifespan extension seen in yeast and worms. Resveratrol has poor bioavailability and rapid metabolism. Quercetin (which does have human RCT data for inflammation) is a more evidence-supported polyphenol for practical supplementation.
What supplements actually extend lifespan in humans?
No supplement has been proven to extend maximum lifespan in humans — that would require a controlled trial lasting 80+ years. What we have is strong evidence that specific supplements reduce all-cause mortality risk in large RCTs followed for 5-10 years (omega-3, vitamin D), improve hallmarks of aging biomarkers (NAD+ precursors, berberine), and preserve the functional capacities most strongly correlated with longevity (creatine for muscle and cognition). The distinction between extending healthspan and extending maximum lifespan is important for setting realistic expectations.